Concepedia

Kamalraj Thiyagarajan

KT

Statistics

Publications

3

Citations

59

H-Index

3

Active since

2013

Affiliations

Bristol-Myers Squibb (United States)(Current)

Biocon (India)

Kamalraj Thiyagarajan is an author at Bristol-Myers Squibb (United States) specializing in medicine, drug discovery, and medicinal chemistry.

Publications per year

2013–2022

3

Publications

3

Discovery of (<i>S</i>)-1-((2′,6-Bis(difluoromethyl)-[2,4′-bipyridin]-5-yl)oxy)-2,4-dimethylpentan-2-amine (BMS-986176/LX-9211): A Highly Selective, CNS Penetrable, and Orally Active Adaptor Protein-2 Associated Kinase 1 Inhibitor in Clinical Trials for the Treatment of Neuropathic Pain

Guanglin Luo, Ling Chen, Walter A. Kostich et al. · Journal of Medicinal Chemistry · 2022 · 32 citations · Full text

, , +12

Reaction of Nitrile Oxides with Masked <i>o</i>‐Benzoquinones; Synthesis of Highly Functionalized Isoxazolines

Santhosh Kumar Chittimalla, Rajesh Kuppusamy, Kamalraj Thiyagarajan et al. · European Journal of Organic Chemistry · 2013 · 16 citations

, , +13

BMS-871: A novel orally active pan-Notch inhibitor as an anticancer agent

Weifang Shan, Aaron Balog, Claude Quesnelle et al. · Bioorganic & Medicinal Chemistry Letters · 2015 · 11 citations · Full text

, , +10

1–3 of 3